Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Bio-Rad Labs Inc. A buy UBS Group AG

Bio-Rad Labs Inc. A
Start price
€316.20
16.02.24 / 50%
Target price
€389.51
16.02.25
Performance (%)
-18.47%
Price
€257.80
26.04.24
Summary
This prediction is currently active. The prediction for Bio-Rad Labs Inc. A disappoints with a performance of -18.47%. This prediction currently runs until 16.02.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Bio-Rad Labs Inc. A -2.422% -2.422%
iShares Core DAX® 2.594% -1.158%
iShares Nasdaq 100 3.553% -1.727%
iShares Nikkei 225® 0.687% -8.354%
iShares S&P 500 2.209% -0.942%

Comments by UBS_Group_AG for this prediction

In the thread Bio-Rad Labs Inc. A diskutieren
Prediction Buy
Perf. (%) -18.47%
Target price 389.508
Change
Ends at 16.02.25

Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target raised by analysts at UBS Group AG from $395.00 to $420.00. They now have a "buy" rating on the stock.
Ratings data for BIO provided by MarketBeat

UBS Group AG 
0
Report Share
16.02.24

Stopped prediction by UBS_Group_AG for Bio-Rad Labs Inc. A

buy
Bio-Rad Labs Inc. A

Start price
Target price
Perf. (%)
€285.60
07.12.23
€365.97
07.12.24
-9.73%
26.04.24

UBS Group AG 
07.12.23 50%